Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Peruana de Ginecología y Obstetricia
versión On-line ISSN 2304-5132
Resumen
GALDOS KAJATT, Oscar. Vaccines against human papillomavirus. Rev. peru. ginecol. obstet. [online]. 2018, vol.64, n.3, pp.437-444. ISSN 2304-5132. http://dx.doi.org/https://doi.org/10.31403/rpgo.v64i2109.
Infection by the human papillomavirus (HPV) is the main factor of cervical cancer. There are currently three vaccines showing efficacy and safety. In Peru, the Ministry of Health has a program of free vaccination for girls aged 9 to 13 years with two doses of tetravalent vaccine (0 and 6 months), whose national coverage is extremely important to reverse the high morbidity and mortality occurring in our country. Older women and boys since age nine can also be vaccinated on their own. This is the main primary prevention that currently exists and must be complemented with secondary prevention.
Palabras clave : Adolescent; Child; Female; Male; Papillomavirus vaccines; Uterine cervical neoplasms; Peru.